Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Endocrine 2 Thoracic 1 NET 1 CNS 1 Breast 1

Conditions

Interventions

Radiotherapy 58 Temozolomide 37 Vincristine 33 Cyclophosphamide 31 Etoposide 25 Carboplatin 25 Filgrastim 23 Cisplatin 22 Granulocyte Colony-Stimulating Factor 18 Lomustine 14 Doxorubicin 13 Chemotherapy, Adjuvant 13 Peripheral Blood Stem Cell Transplantation 12 Magnetic Resonance Spectroscopy 12 Topotecan 11 Radiation 11 Isotretinoin 11 Platinum 10 sargramostim 9 Specimen Handling 9 Radiotherapy, Conformal 9 Irinotecan 9 Carmustine 9 1,2-diaminocyclohexaneplatinum II citrate 9 etoposide phosphate 8 Thiotepa 8 Radiotherapy, Intensity-Modulated 8 Radiosurgery 8 Melphalan 8 Immunohistochemistry 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Octreotide × CNS × Clear all

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡